Miranda L. Xu

850 citations
31 papers · 693 indexed · h-index 18
Topics
Cholinesterase and Neurodegenerative Diseases (12 papers)Traditional Chinese Medicine Analysis (4 papers)Ginseng Biological Effects and Applications (3 papers)
Partner nations
Hong KongChinaMacao

In The Last Decade

Miranda L. Xu

31 papers receiving 688 citations

Peers

Miranda L. Xu
Comparison fields: 5 of 93
  • Molecular Biology 366
  • Pharmacology 137
  • Complementary and alternative medicine 111
  • Cancer Research 107
  • Pharmacology 79
Replace Kar‐Lok Wong with:
Kar‐Lok Wong Taiwan
Jinman Chen China
Xiaomei Bao China
Jia Cui China
Cui Yang China
Zhimin Ou China
Junxia Xie China
Senthilkumar Krishnamoorthi India
Miranda L. Xu relative to Kar‐Lok Wong Taiwan Kar‐Lok Wong's profile →
Citations per field
00.5×1.5×2.0×
Kar‐Lok Wong · 1×
Citations per year

Countries citing papers authored by Miranda L. Xu

Since Specialization
Citations

This map shows the geographic impact of Miranda L. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda L. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda L. Xu more than expected).

Fields of papers citing papers by Miranda L. Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda L. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda L. Xu. The network helps show where Miranda L. Xu may publish in the future.

Co-authorship network of co-authors of Miranda L. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda L. Xu. A scholar is included among the top collaborators of Miranda L. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda L. Xu. Miranda L. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 11
3 37
4 6
5 13
6 20
7 32
8 17
9 30
10 3
11 4
12 24
13 27
14 6
15 31
16 54
17 11
18 9
19 9
20 16

About Miranda L. Xu

Miranda L. Xu is a scholar working on Pharmacology, Complementary and alternative medicine and Pharmacology, having authored 31 papers that have together received 693 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (12 papers), Traditional Chinese Medicine Analysis (4 papers) and Ginseng Biological Effects and Applications (3 papers). The work is most often cited by research in Complementary and alternative medicine (111 citations), Pharmacology (79 citations) and Pharmacology (137 citations). Miranda L. Xu has collaborated with scholars based in Hong Kong, China and Macao. Frequent co-authors include Karl Wah Keung Tsim, Tina T. X. Dong, Tina Ting-Xia Dong, Cathy W.C. Bi, Xiangpeng Kong, Yingjie Xia, Qiyun Wu, Anna Xiaodan Yu, Amy G. W. Gong and Huai‐You Wang. Their work appears in journals such as Journal of Biological Chemistry, Brain Research and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026